v3.25.2
Segment information - Information by Segment on Current Cost of Supplies Basis (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disclosure of operating segments [line items]      
Revenue $ 316,620 $ 381,314 $ 261,504
Share of profit/(loss) of joint ventures and associates (CCS basis) 3,758 3,930 3,913
Interest and other income, of which: 2,838 915 7,056
Interest income 2,313 1,046 511
Net gains/(losses) on sale and revaluation of non-current assets and businesses 257 642 5,995
Other 268 (773) 550
Total expenditure 290,556 321,386 242,828
Production and manufacturing expenses 25,240 25,518 23,822
Selling, distribution and administrative expenses 13,433 12,883 11,328
Research and development expenses 1,287 1,075 815
Exploration expenses 1,750 1,712 1,423
Depreciation, depletion and amortisation charge, of which: 31,290 18,529 26,921
Impairment losses 8,947 2,313 4,065
Impairment reversals (762) (6,177) (214)
Interest expense 4,673 3,181 3,607
Taxation charge/(credit) (CCS basis) 13,194 21,497 8,391
Other revenue 15,607 11,708 126
Impairment losses on property, plant and equipment 8,182 1,799 3,894
Goodwill 635 361 167
Intangible assets other than goodwill 130 153 4
Reversal of impairment loss recognised in profit or loss, property, plant and equipment 627 6,177 214
Intangible assets other than goodwill 135 0 0
Decrease through write-off, financial assets   1,126  
Purchase contract      
Disclosure of operating segments [line items]      
Reversal of losses (gains) on sales contracts 2,074 7,201 4,892
Sales contract      
Disclosure of operating segments [line items]      
Reversal of losses (gains) on sales contracts (4,689) (9,815) (4,824)
CCS earnings      
Disclosure of operating segments [line items]      
Taxation charge/(credit) (CCS basis) 203 (444) (808)
CCS earnings 20,281 41,562 17,482
Inter-segment      
Disclosure of operating segments [line items]      
Revenue 60,373 80,778 50,680
Operating segments      
Disclosure of operating segments [line items]      
Third-party and inter-segment purchases (CCS basis) 272,441 340,980 229,364
Total expenditure 39,960 39,476 35,965
Production and manufacturing expenses 25,240 25,518 23,822
Selling, distribution and administrative expenses 13,433 12,883 11,328
Research and development expenses 1,287 1,075 815
Exploration expenses 1,750 1,712 1,423
Depreciation, depletion and amortisation charge, of which: 31,290 18,529 26,921
Impairment losses 8,947 2,313 4,065
Impairment reversals (762) (6,177) (214)
Interest expense 4,673 3,181 3,607
Integrated Gas      
Disclosure of operating segments [line items]      
Revenue 37,645 54,751 29,922
Share of profit/(loss) of joint ventures and associates (CCS basis) 1,951 1,219 1,933
Interest and other income, of which: 137 (714) 1,596
Interest income 6 43 0
Net gains/(losses) on sale and revaluation of non-current assets and businesses (22) 101 1,610
Other 153 (858) (14)
Taxation charge/(credit) (CCS basis) 2,803 5,899 2,648
Reversal of impairment loss recognised in profit or loss, property, plant and equipment 325 3,449  
Integrated Gas | CCS earnings      
Disclosure of operating segments [line items]      
CCS earnings 7,046 22,212 8,060
Integrated Gas | Inter-segment      
Disclosure of operating segments [line items]      
Revenue 11,560 18,412 8,072
Integrated Gas | Operating segments      
Disclosure of operating segments [line items]      
Third-party and inter-segment purchases (CCS basis) 27,356 37,785 20,188
Total expenditure 4,823 5,237 4,526
Production and manufacturing expenses 4,529 4,907 4,194
Selling, distribution and administrative expenses 168 218 231
Research and development expenses 126 112 101
Exploration expenses 216 240 122
Depreciation, depletion and amortisation charge, of which: 8,903 2,211 5,908
Impairment losses 3,472 115 723
Impairment reversals (324) (3,449) (204)
Interest expense 146 84 71
Upstream      
Disclosure of operating segments [line items]      
Revenue 6,475 8,352 9,182
Share of profit/(loss) of joint ventures and associates (CCS basis) 768 2,111 632
Interest and other income, of which: 671 726 4,592
Interest income 27 22 37
Net gains/(losses) on sale and revaluation of non-current assets and businesses 209 437 4,130
Other 435 267 425
Taxation charge/(credit) (CCS basis) 8,377 14,070 6,057
Impairment losses on property, plant and equipment   320  
Reversal of impairment loss recognised in profit or loss, property, plant and equipment 203 2,504  
Upstream | CCS earnings      
Disclosure of operating segments [line items]      
CCS earnings 8,528 16,222 9,603
Upstream | Inter-segment      
Disclosure of operating segments [line items]      
Revenue 41,230 52,285 35,789
Upstream | Operating segments      
Disclosure of operating segments [line items]      
Third-party and inter-segment purchases (CCS basis) 7,890 10,666 9,094
Total expenditure 9,845 10,365 10,322
Production and manufacturing expenses 9,186 9,676 9,797
Selling, distribution and administrative expenses 163 233 186
Research and development expenses 496 456 339
Exploration expenses 1,534 1,472 1,301
Depreciation, depletion and amortisation charge, of which: 12,463 10,334 13,485
Impairment losses 1,360 950 920
Impairment reversals (206) (2,504) (9)
Interest expense 507 345 333
Marketing      
Disclosure of operating segments [line items]      
Revenue 108,858 120,638 83,494
Share of profit/(loss) of joint ventures and associates (CCS basis) 548 237 385
Interest and other income, of which: 76 (104) 278
Interest income 9 0 3
Net gains/(losses) on sale and revaluation of non-current assets and businesses 16 (186) 285
Other 51 82 (10)
Taxation charge/(credit) (CCS basis) 819 903 903
Marketing | CCS earnings      
Disclosure of operating segments [line items]      
CCS earnings 2,950 2,133 3,535
Marketing | Inter-segment      
Disclosure of operating segments [line items]      
Revenue 624 606 254
Marketing | Operating segments      
Disclosure of operating segments [line items]      
Third-party and inter-segment purchases (CCS basis) 94,614 108,012 70,745
Total expenditure 9,336 8,383 7,501
Production and manufacturing expenses 949 810 950
Selling, distribution and administrative expenses 8,137 7,351 6,384
Research and development expenses 250 222 167
Exploration expenses 0 0 0
Depreciation, depletion and amortisation charge, of which: 2,335 1,900 1,700
Impairment losses 420 480 129
Impairment reversals (1) (151) (1)
Interest expense 52 46 27
Chemicals and Products      
Disclosure of operating segments [line items]      
Revenue 118,781 144,342 116,448
Share of profit/(loss) of joint ventures and associates (CCS basis) 590 374 989
Interest and other income, of which: 61 244 37
Interest income 57 24 36
Net gains/(losses) on sale and revaluation of non-current assets and businesses (61) 282 (24)
Other 65 (62) 25
Taxation charge/(credit) (CCS basis) (198) 935 (210)
Impairment losses on property, plant and equipment   257  
Chemicals and Products | CCS earnings      
Disclosure of operating segments [line items]      
CCS earnings 1,530 4,515 404
Chemicals and Products | Inter-segment      
Disclosure of operating segments [line items]      
Revenue 2,252 2,684 1,890
Chemicals and Products | Operating segments      
Disclosure of operating segments [line items]      
Third-party and inter-segment purchases (CCS basis) 102,396 127,521 103,294
Total expenditure 11,483 11,362 10,347
Production and manufacturing expenses 7,908 7,583 6,815
Selling, distribution and administrative expenses 3,323 3,592 3,375
Research and development expenses 252 187 157
Exploration expenses 0 0 0
Depreciation, depletion and amortisation charge, of which: 6,411 3,289 5,485
Impairment losses 2,787 356 2,248
Impairment reversals (90) (73) 0
Interest expense 62 22 44
Renewables and Energy Solutions      
Disclosure of operating segments [line items]      
Revenue 44,819 53,190 22,415
Share of profit/(loss) of joint ventures and associates (CCS basis) (96) (7) (27)
Interest and other income, of which: 75 57 200
Interest income 12 (2) 4
Net gains/(losses) on sale and revaluation of non-current assets and businesses 110 8 (6)
Other (47) 51 202
Taxation charge/(credit) (CCS basis) 1,303 (303) (342)
Renewables and Energy Solutions | CCS earnings      
Disclosure of operating segments [line items]      
CCS earnings 3,038 (1,059) (1,514)
Renewables and Energy Solutions | Inter-segment      
Disclosure of operating segments [line items]      
Revenue 4,707 6,791 4,675
Renewables and Energy Solutions | Operating segments      
Disclosure of operating segments [line items]      
Third-party and inter-segment purchases (CCS basis) 40,170 57,024 26,048
Total expenditure 3,831 3,590 2,745
Production and manufacturing expenses 2,610 2,520 2,098
Selling, distribution and administrative expenses 1,058 972 596
Research and development expenses 163 98 51
Exploration expenses 0 0 0
Depreciation, depletion and amortisation charge, of which: 1,159 777 326
Impairment losses 908 412 45
Impairment reversals (141) 0 0
Interest expense 4 2 0
Corporate      
Disclosure of operating segments [line items]      
Revenue 42 41 43
Share of profit/(loss) of joint ventures and associates (CCS basis) (3) (4) 1
Interest and other income, of which: 1,818 706 353
Interest income 2,202 959 431
Net gains/(losses) on sale and revaluation of non-current assets and businesses 5 0 0
Other (389) (253) (78)
Taxation charge/(credit) (CCS basis) 90 (7) (665)
Corporate | CCS earnings      
Disclosure of operating segments [line items]      
CCS earnings (2,811) (2,461) (2,606)
Corporate | Inter-segment      
Disclosure of operating segments [line items]      
Revenue 0 0 0
Corporate | Operating segments      
Disclosure of operating segments [line items]      
Third-party and inter-segment purchases (CCS basis) 15 (28) (5)
Total expenditure 642 539 524
Production and manufacturing expenses 58 22 (32)
Selling, distribution and administrative expenses 584 517 556
Research and development expenses 0 0 0
Exploration expenses 0 0 0
Depreciation, depletion and amortisation charge, of which: 19 18 17
Impairment losses 0 0 0
Impairment reversals 0 0 0
Interest expense $ 3,902 $ 2,682 $ 3,132